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Abstract: The 2005–2006 outbreak of Fusarium keratitis associated with soft hydrophilic 
contact lens wear was both unprecedented and unexpected. More than 250 cases have been 
reported worldwide that have primarily been associated with Bausch & Lomb ReNu with 
MoistureLoc and, more recently, with Bausch and Lomb ReNu MultiPlus multipurpose contact 
lens disinfecting solutions. This article documents the outbreak, presenting the time line and 
the historical and scientiﬁ  c basis for its occurrence. Underlying causes are explored including 
likely mechanisms of contamination and subsequent corneal infection. Thorough exploration 
of this unique occurrence affords the opportunity to examine contact lens and lens care actions 
and interactions and to develop greater understanding of possible associated risks and ways to 
minimize them.
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Introduction
Hydrophilic soft contact lenses were invented in 1961 by Czechoslovakian chemist 
Professor Otto Wichterle and ﬁ  rst commercially introduced in the United States by 
Bausch & Lomb in 1971. In the more than three decades since their introduction, 
hydrophilic soft contact lenses have proven a comparatively safe and effective form 
of vision correction.
The majority of complications associated with hydrophilic lenses are minor and 
self-limiting, however contact lens related microbial keratitis (CL-MK) stands out 
as a potentially sight threatening and sometimes life altering event. The relative risk 
of infectious keratitis has been extensively investigated; however, the underling risk 
factors much less so. Length of continuous lens wear, particularly overnight wear, 
has been identiﬁ  ed as a key factor in lens-related microbial keratitis. Several studies 
suggest that relative risk increases from approximately 4 in 10,000 for daily wear 
to 20 in 10,000 for extended wear (Poggio et al 1989; Schein et al 1989; Cheng 
et al 1999).
Other factors have been recognized but generally are assumed to play contributory 
or relatively minor roles in the genesis of CL-MK (Weissman and Mondino 2002). 
They include hypoxia, non-compliance with lens care regimens, blepharitis, diabetes 
mellitus, epithelial trauma, steroid use, tobacco use, and therapeutic lens use. Envi-
ronmental factors such travel to warm climates have also been implicated.
The role contact lens materials play in the genesis of CL-MK has been explored, 
albeit indirectly. Post-approval surveillance and other studies regarding silicone 
hydrogel-based contact lenses have shown relatively little difference in the incidence 
of presumed microbial keratitis compared to conventional hydrogel lenses (Schein 
et al 2005). The roles of potentially important contributory factors such as lens care 
products, their constituents, lens designs, and interactions among these elements have Clinical Ophthalmology 2007:1(4) 356
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been largely ignored both clinically and scientiﬁ  cally. Based 
on current knowledge, CL-MK appears to be both multi-
factorial and complex.
The overwhelming majority of CL-MK cases have been 
attributed to infection by Gram-negative bacteria, primarily 
Pseudomonas and Serratia spp (Cheng et al 1999; Schaefera 
et al 2001; Robertson et al 2007). Pseudomonas is one of the 
few pathogens known to be capable of penetrating an intact 
corneal epithelium (Fleiszig et al 1998). CL-MK has been 
associated with other pathogens including acanthamoeba spp. 
and, rarely fungi. The incidence of reported fungal keratitis 
has been low compared to bacterial keratitis with the excep-
tion of occurrences in tropical climates and in surface or 
immune compromised individuals, especially those wearing 
extended wear or therapeutic bandage contact lenses.
In South Florida, which has historically been the epicenter 
of fungal keratitis in the US, a review of records from January 
1982 and January 1992 found trauma to be the most common 
risk factor (44%) (Rosa et al 1994). Five cases were linked to 
extended wear contact lenses (4%) and one to a therapeutic 
bandage contact lens (1%).
In a retrospective review of culture-positive fungal keratitis 
at the Singapore National Eye Center and Singapore General 
Hospital from January 1991 to December 1995, twenty-nine 
cases of culture-positive fungal keratitis were reported. More 
than half of the patients had a history of ocular trauma while 
a quarter had prior topical corticosteroid therapy. Only two 
patients were contact-lens wearers (Wong et al 1997).
Reports describing a dramatic rise in the incidence of 
contact lens-related fungal keratitis later found to be asso-
ciated with Bausch and Lomb ReNu with MoistureLoc 
multipurpose solution began in 2005 and continued into 
2006. Initial reports came from Hong Kong and Singapore. 
By February 2006, reports appeared in the Asian press. On 
March 8, 2006, the United States Centers for Disease Con-
trol (CDC) received a report of three patients with contact 
lens-associated Fusarium keratitis from David S. Chu, MD, a 
New Jersey ophthalmologist and cornea specialist (US CDC 
2006a). The outbreak had come to the United States and was 
soon to become a global mini-epidemic. This paper docu-
ments the Fusarium outbreak with particular focus on the 
time line, epidemiology, mechanisms underlying disinfectant 
failure and the relevant pathophysiology of fungal infection 
in contact lens wearers.
Origins of the outbreak: Time line
Although ReNu® with MoistureLoc’s® proclivity for fungal 
growth was ﬁ  rst discovered accidentally in January of 2005 
(Epstein 2007) its clinical impact remained unrecognized 
for more than a year. The first signs of an outbreak 
were discovered in Hong Kong and then in Singapore. 
Ophthalmologists at the Hong Kong Hospital Authority 
initially voiced concern in July 2005 during a periodic 
review of emerging cases regarding “an unusually high 
yield of Fusarium from patients’ clinical specimens sent for 
culture” (Hong Kong Hospital Authority 2006). As a result, 
Hong Kong’s health department issued an alert in August 
2005 based on reports of four patients in public hospitals 
with CL-MK in July and August. The public was warned 
to clean contact lenses carefully and to use appropriate 
hygiene. These cases were reported to Bausch & Lomb and 
apparently were investigated; however, a link between these 
emerging cases and B&L lens care products was not found. 
Several months later investigators in Singapore uncovered 
the relationship.
On January 27, 2006, Donald Tan, MD, the deputy 
director of Singapore’s National Eye Center (SNEC) sent a 
letter to the Singapore Ministry of Health (MOH) describing 
thirteen Fusarium cases in contact lens wearers all of whom 
used Bausch & Lomb’s ReNu with MoistureLoc multipur-
pose solution. As a result, the Singapore Ministry of Health 
issued a public alert regarding the “Increasing Incidence 
of Contact Lens Related Fungal Corneal Infections” on 
February 17, 2006. The alert detailed nineteen patients that 
had been treated at SNEC for culture positive fungal keratitis 
due to Fusarium since May 2005 and an additional three cases 
reported by Changi General Hospital.
As the numbers of infected patients in Singapore mounted, 
the MOH advised that “as a precautionary measure for con-
tact lens users to discontinue using Bausch and Lomb’s ReNu 
multipurpose contact lens solution for the time being” on 
February 20, 2006 (Update 2). On February 21 (Update 3), 
the Singapore MOH announced that Bausch & Lomb was 
voluntarily suspending sales of ReNu multipurpose solutions. 
They further announced “In view of the potentially serious 
adverse visual consequences of fungal corneal infection, the 
Ministry of Health strongly advises all contact lens users 
as a precautionary measure to discontinue the use of B & L 
ReNu multipurpose contact lens solution for the time being, 
until the causes behind this recent increase in infections can 
be more clearly ascertained. B&L will advise consumers on 
what to do with existing stocks of their product.”
On April 12, 2006 in an Update on Contact Lens 
Related Fungal Infections, the Singapore MOH reported the 
following: “A comprehensive case-control study (compar-
ing contact lens users with infection and contact lens users Clinical Ophthalmology 2007:1(4) 357
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without corneal infection was undertaken in Feb-Mar 2006 
to investigate risk factors for the spike in fungal corneal 
infection. The study found a strong association between cor-
neal infection and the use of ReNu solution. This association 
remained strong even after taking into consideration socio-
demographic, lens, hygiene and environmental factors. The 
ﬁ  ndings are also consistent with recent observations made 
in the US and Hong Kong.”
Based largely on the quickly circulating report of New 
Jersey cornea specialist Dr. David Chu, the City of New York 
Department of Health and Mental hygiene issued 2006 Alert 
#6 on March 14, 2006, warning both public and professional 
communities about the association of Fusarium keratitis and 
soft contact lens wear.
After meeting with representatives of Bausch & Lomb, 
on March 30, 2006 ofﬁ  cers of the American Optometric 
Association (AOA) and the AOA Contact Lens & Cornea 
Section met on March 31, 2006. An urgent response to the 
Fusarium outbreak was approved and on April 3, 2006, the 
AOA issued a press release and a clinical advisory regarding 
the Fusarium outbreak in the United States. Optometrists in 
the United States were advised to be vigilant and consider 
a fungal etiology when encountering CL-MK. The press 
quickly disseminated this information and on April 5, 2006, 
Good Morning America, a national morning television pro-
gram televised a segment on the Fusarium outbreak.
On March 31, 2006, Bausch & Lomb issued their ﬁ  rst 
press release discussing the Fusarium outbreak and their man-
agement of the situation. They described interaction with the 
US CDC and collaboration of the Johns Hopkins Wilmer Eye 
Institute and the CDC to implement a surveillance program 
at leading corneal treatment centers in the US. Top experts 
in corneal infectious disease as well as microbiologists spe-
cializing in fungi were retained to collect and culture clinical 
isolates of Fusarium from patient samples and identify the 
genotypes of retained specimens in an attempt to determine 
if they represented uncommon variants. Bausch & Lomb 
also announced their collaboration with health authorities in 
Singapore and Hong Kong in completing the aforementioned 
case control study. The remainder of the press release focused 
on poor patient compliance as a root cause of the outbreak 
and the results of extensive testing that conﬁ  rmed that ReNu 
with MoistureLoc was sterile and effective. Bausch & Lomb 
again reminded contact lens wearers of the importance of 
proper lens care in an April 7, 2006 press release.
The public response from US government agencies 
followed soon after. On April 10, 2006, the US Centers 
for Disease Control and Prevention (CDC) and US Food 
and Drug Administration (FDA) issued public health alerts 
about the rise in reports in the US of CL-related Fusarium 
keratitis.
The CDC reported 109 cases of suspected fungal kera-
titis in seventeen different states. Of particular note was the 
geographic distribution, with many of the cases occurring 
in areas where fungal keratitis was rarely if ever clinically 
encountered. This included states in the Northeast and 
North Dakota. Complete data was available for thirty of the 
case patients as of April 10. Twenty-eight of the thirty case 
patients wore soft contact lenses, and twenty-six of those 
twenty-eight used different types of Bausch & Lomb ReNu 
brand contact lens solution in the month prior to the onset 
of infection. Eight patients required corneal transplantation 
(US CDC 2006a).
In a terse response to the initial CDC report Bausch and 
Lomb announced on April 10, 2006, that it was temporarily 
suspending U.S. shipments of ReNu® with MoistureLoc® lens 
care solutions produced in its Greenville, SC, manufacturing 
facility. This limited response to the worsening crisis was not 
well received by the press or the ﬁ  nancial community with 
several critical articles and commentaries quickly appear-
ing in the media. Subsequently, in a press release issued 
April 13, 2006, Bausch & Lomb requested that retailers 
remove US-manufactured ReNu with MoistureLoc from 
shelves and recommended that consumers switch to another 
solution pending further investigation. The company also 
placed ads in USA Today and regional newspapers on April 
14 and 16 with Bausch & Lomb Chairman and CEO Ron 
Zarrella explaining the situation and providing guidance on 
alternatives.
In a May 5, 2006 update, the US CDC reported 102 con-
ﬁ  rmed cases, twelve possible cases and eighty-one cases still 
under investigation from thirty-one US states and territories 
(US CDC 2006b).
Of the ﬁ  fty eight conﬁ  rmed cases for which CDC had 
complete data:
•  56 wore contact lenses
•  32 reported using any B&L ReNu with MoistureLoc
•  15 reported using any B&L ReNu MultiPlus
•  7 reported using any unspeciﬁ  ed B&L ReNu
•  3 reported using any AMO product
•  3 reported using any Alcon product
Some cases reported using more than one type of solu-
tion, therefore the solution categories are not mutually 
exclusive.
In a response to the CDC, dated May 3, 2006 (which 
was initially released on May 2), Bausch & Lomb offered Clinical Ophthalmology 2007:1(4) 358
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the following: “These preliminary data require further 
examination and should be placed in proper context. Studies 
suggest that Fusarium keratitis occurs among contact lens 
wearers at a low rate. It would be expected that the distribu-
tion of lens care products associated with these cases would 
be roughly proportional to the products’ relative market 
share. In the small sample of cases CDC has analyzed to 
date, the 27-percent representation of ReNu® MultiPlus® 
solution is well below its approximate 40-percent market 
share. The 57-percent share of cases preliminarily reported 
for the company’s MoistureLoc formula is signiﬁ  cantly 
and disproportionately higher than its U.S. market share of 
less than 10 percent, which represents approximately 2.3 
million users. This disproportionate representation of the 
MoistureLoc formula in the CDC case reports is the reason 
Bausch & Lomb voluntarily withdrew MoistureLoc from 
the market while the investigation to determine the cause 
of these unusual infections continues.” It should be noted 
that no explanation was offered for the disproportionately 
low incidence of cases associated with other products, par-
ticularly Alcon Laboratory’s OptiFree products that were 
linked to only three cases (5%) despite having a market share 
comparable to ReNu MultiPlus, which was associated with 
27% of cases.
A May 12, 2006, CDC press release detailed reports 
of 122 conﬁ  rmed cases, ﬁ  fteen possible cases and sixty 
cases still under investigation from thirty-three U.S. states 
and territories. Seventy-ﬁ  ve reports included insufﬁ  cient 
evidence to classify them as cases or carry other non-
Fusarium diagnoses. States or territories with at least one 
conﬁ  rmed or possible case included: Arkansas, Arizona, 
California, Connecticut, Florida, Georgia, Iowa, Illinois, 
Kansas, Kentucky, Louisiana, Massachusetts, Maryland, 
Michigan, Missouri, North Carolina, North Dakota, New 
Jersey, New York, Ohio, Oklahoma, Pennsylvania, Puerto 
Rico, Tennessee, Texas and Vermont. States where cases 
were currently under investigation included: Indiana, 
Minnesota, Mississippi, Nevada, Oregon, Rhode Island, 
and Virginia (US CDC 2006c).
With the evidence continuing to mount linking ReNu 
with MoistureLoc to the Fungal keratitis outbreak, Bausch 
& Lomb, in a press conference and subsequent press release 
dated May 15, 2006, announced a global voluntary recall of 
MoistureLoc. Ron Zarrella, B&L CEO was quoted, “After an 
extensive investigation involving thousands of tests, millions 
of dollars and collaboration with government agencies, health 
authorities and independent experts, there is no evidence of 
product contamination, tampering, counterfeiting or sterility 
failure. That leads us to conclude that some aspect of the 
MoistureLoc formula may be increasing the relative risk of 
Fusarium infection in unusual circumstances.”
In a ﬁ  nal update, Fusarium Keratitis—United States, 
2005–2006 published in the May 26, 2006 MMWR, the 
CDC reported 130 conﬁ  rmed cases and announced its ﬁ  nal 
determination (US CDC 2006d).
Among 125 contact lens wearers, 118 were able to iden-
tify which contact lens solution(s) they had used during the 
month before onset of infection. Seventy-ﬁ  ve (64%) reported 
using Bausch & Lomb’s ReNu with MoistureLoc alone, four-
teen (12%) reported using MoistureLoc in combination with 
another product, eight (7%) reported using an unspeciﬁ  ed 
Bausch and Lomb solution, and twenty-one (18%) reported 
using only products other than MoistureLoc, from various 
manufacturers. Corneal transplantation was required in 31% 
of cases. The results of the CDC case-control investigation 
indicated increased risk for Fusarium keratitis associated with 
use of Bausch & Lomb’s ReNu with MoistureLoc.
The CDC data were subsequently updated and published 
in the Journal of the American Medical Association. As 
of June 30, 2006, 164 conﬁ  rmed cases were identiﬁ  ed in 
thirty-three states and one US territory. Corneal transplan-
tation was required or planned in ﬁ  fty-ﬁ  ve patients (34%). 
Fusarium was not recovered from the factory, warehouse, 
solution ﬁ  ltrate, or unopened solution bottles; production of 
implicated lots was not clustered in time. Among thirty-nine 
isolates tested, at least ten different Fusarium species were 
identiﬁ  ed, comprising nineteen unique multilocus genotypes 
(Chang et al 2006).
Summary reports from Singapore and the Untied States 
have been published. In Singapore from March 1, 2005, to 
May 31, 2006, sixty-six patients (sixty-eight affected eyes) 
were diagnosed with contact lens related Fusarium keratitis; 
the estimated annual national incidence was 2.35 cases per 
10,000 contact lens wearers with more than 98% wearing 
soft, disposable lenses. Sixty-two patients (93.9%) reported 
using ReNu solution with forty-two patients (63.6%) speciﬁ  -
cally reporting use of ReNu with MoistureLoc. Most patients 
(81.8%) reported poor contact lens hygiene practices (Khor 
et al 2006).
Results of a subsequent case-control study evaluating risk 
factors for contact lens-related Fusarium keratitis in contact 
lens users in Singapore from March 2005 through May 2006 
has been published. It included 61 patients with Fusarium kera-
titis and 188 population-based and 179 hospital-based control 
subjects. Patients with Fusarium keratitis were found to have 
been more likely to use Bausch & Lomb ReNu contact lens Clinical Ophthalmology 2007:1(4) 359
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solutions than were either population-based or hospital-based 
control subjects. After controlling for age, sex, contact lens 
hygiene, and other factors, the use of ReNu with MoistureLoc 
signiﬁ  cantly increased the risk of Fusarium keratitis. The risk 
associated with ReNu with MoistureLoc was 5 times higher 
compared to the still signiﬁ  cant risk of using ReNu MultiPlus. 
The authors concluded that use of ReNu contact lens solutions 
signiﬁ  cantly increased the risk of contact lens-related Fusarium 
keratitis in Singapore and called for further investigations into 
the role of ReNu MultiPlus in the development of Fusarium 
keratitis in other populations (Saw et al 2007).
In the United States, several groups reported on the 
outbreak. Bascom Palmer Eye Institute in Miami, Florida, 
reported treating ten cases of soft contact lens-associated 
keratomycosis between 1969 and 1992. Three cases of fungal 
keratitis associated with contact lenses were seen between 
1969 and 1977, two between 1977 and 1982 and ﬁ  ve between 
1982 and 1992. In contrast, between January 2004 and April 
2006, thirty-four cases at Bascom Palmer were attributed to 
Fusarium infection (Alfonso, Cantu-Dibildox, et al 2006). 
Fungal pathogens in CL-MK increased from 26.7% (eight 
of thirty) to 50% (eighteen of thirty-six) of isolates in 2005. 
Fusarium species (66 of 122, 54.1%) were the most frequent 
fungal pathogens (Alfonso, Miller, et al 2006). Fungal 
keratitis is rare in non-tropical or sub-tropical areas. Despite 
this well recognized climate-associated pattern, Fusarium 
CL-MK was reported in states including Pennsylvania, Ohio, 
and California even during the cold winter months (Bernal 
et al 2006; Cohen 2006; Jeng et al 2006).
Origins of the problem
A variety of possible etiologies were proposed and dis-
seminated to professional groups and the press by Bausch & 
Lomb soon after the Fusarium outbreak was identiﬁ  ed in 
the US. During a March 30, 2006 brieﬁ  ng on the status of 
the Fusarium investigation presented to the AOA and AOA 
Contact Lens & Cornea Section leadership by B&L Director 
of Medical Marketing Gary Orsborn, MS, OD, the following 
possible etiologies were suggested:
•  Poor patient hygiene and non-compliance with manufac-
turer or practitioner recommendations
•  Contamination of the manufacturing plant or some aspect 
of the manufacturing process
•  Contamination of bottles after leaving the factory either 
during transport or storage
•  The recent Asian tsunami and hurricane Katrina causing 
shifts in the ecosystem resulting in new, more virulent 
strains of Fusarium and possibly other fungi
• Signiﬁ  cant diversity of genotypes found in clinical 
isolates
•  Fusarium contamination of non-preserved ﬂ  uoroqui-
nolones drops used to treat CL-MK resulting in super-
infection
Of these, poor patient compliance was highlighted as the 
most likely etiologic factor. Initial data from the Singapore 
Eye Research Institute found that more than 80% of infected 
patients reported poor hygienic practices. (Khor et al 2006). 
However, comparison to historical data suggests that patient 
non-compliance did not worsen signiﬁ  cantly during the 
Fusarium outbreak, certainly not sufﬁ  ciently to explain 
such a large scale occurrence. Claydon and Efron reported 
contact lens non-compliance in the use of recommended 
care and maintenance regimens in 40 to 91% of contact lens 
patients with many who were confused or ignorant about 
their behavior (Claydon and Efron 1994). Other researchers 
reported similar ﬁ  ndings (Sokol et al 1990).
Non-compliance as a primary factor was made even 
more unlikely by genetic analysis of clinical isolates, which 
revealed a diverse array of Fusarium solani genotypes. The 
broad genetic diversity and the fact that a preponderance 
of phylogenetic species are viewed as commonly found 
and associated with sinks and drains suggest the source 
of inoculation in these cases of keratitis was most likely 
from strains resident in the water systems of the patients’ 
homes (Levy et al 2006). Simple logic would suggest that 
non-hygienic patients who failed to wash their hands prior 
to handling lenses would be less likely to encounter and 
transfer a fungal inoculum to the lens, case or eye than a 
compliant patient exposed to sinks and drains during hand 
washing.
Possible contamination of the manufacturing facility was 
considered. Extensive investigation by both the US FDA and 
B&L found no point source of contamination. Likewise, no 
problems were uncovered with the packaging or transport 
of the product. The genetic diversity of isolates weighed 
heavily against this theory throughout the investigation. No 
contamination was found in any bottles, and all tested product 
was found stable and effective. This additional information 
conﬁ  rmed that the outbreak was due to disinfection failure 
occurring during product use by patients.
The issue of climatic change was considered by several 
people including Bausch and Lomb’s CEO, Ronald Zarrella. 
He was quoted in a Washington Times article published April 
13, 2006 “There’s been theories all the way from, ‘Has the 
tsunami ... hurricanes and the effect of environmental factors 
created mold levels that are unprecedented?”Clinical Ophthalmology 2007:1(4) 360
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More recently, Iyer, and coworkers from the University 
of Florida at Gainesville published a retrospective review of 
fungal keratitis at their institution from 1999 through June 
2006 (Iyer et al 2006). Their results suggest that, at least at 
their institution, contact lenses represent a major risk factor 
for fungal keratitis; furthermore, the incidence of contact 
lens–related fungal keratitis was increasing even before the 
Fusarium outbreak in 2005 and 2006.
Fungal contamination of non-BAK preserved antibiotic 
bottles has been anecdotally described in scientiﬁ  c posters 
and the ophthalmic press, but the clinical relevance has never 
been established (Mack 2006; Ashford 2006). Other studies 
suggest that microbial contamination of the contents of an 
antibiotic bottle is unlikely.
Cultures of bottles used by individual patients and in a 
multidose ofﬁ  ce or hospital setting have demonstrated no 
clinically signiﬁ  cant contamination (Mason et al 2005). 
Fungi are saprophytes that derive nutrition from organic 
matter. The environment within an antibiotic bottle does not 
support fungal growth. Additional evidence that ﬂ  uoroqui-
nolones did not foster the Fusarium outbreak is the reported 
efﬁ  cacy of commercial non-preserved moxiﬂ  oxacin 0.5% 
(Vigamox, Alcon Labs, Ft. Worth, TX) against culture posi-
tive Fusarium cases (Munir et al 2006).
While climatic change may be inﬂ  uencing shifts in the 
prevalence and severity of mycotic disease, the contribution 
of climatic shift in the Fusarium keratitis outbreak is likely 
small. Other factors, speciﬁ  cally solution formulation issues 
and inadequate testing, are more likely key contributors to 
this epidemic (US FDA 2006).
Current disinfectant standards
for contact lens care products
In 1997, the US Food and Drug Administration adopted an 
updated standard for contact lens care product disinfection. 
A 172-page guidance document containing speciﬁ  c direc-
tion for still current “stand-alone” disinfection approval 
was disseminated (US FDA 1997). Subsequently, the Inter-
national Organization for Standardization (ISO) developed 
and promulgated a newer standard, which was designed to 
harmonize numerous differing country-speciﬁ  c standards 
(Rosenthal, Sutton, et al 2002). The ISO 14729 procedure 
was introduced in 2001 (ISO 2001).
The current ISO 14729 standard consists of two parts. 
A “Stand Alone” test which evaluates the disinfecting 
solution’s innate antimicrobial activity. Upon passing this 
test, the product is exempted from additional testing using 
the “Regimen Test”. The Stand Alone test assumes that in 
conjunction with rubbing and rinsing steps, the disinfectant 
will be capable of passing a more stringent regimen criteria. 
The Regimen Test evaluates the antimicrobial efﬁ  cacy of 
the entire regimen as described in the package insert (e.g., 
rubbing, rinsing, and disinfecting).
The US FDA had come under harsh criticism during the 
Fusarium outbreak for maintaining insufﬁ  ciently robust stan-
dards and failing to revise them despite signiﬁ  cant advances 
in contact lens materials and lens care products. However, 
current ISO standards were actually exceeded at the time of 
the outbreak.
Evidence had been accumulating for several years regard-
ing the interaction between disinfecting solutions and lens 
materials. Loss of disinfecting efﬁ  cacy after lenses were 
soaked in biguanide disinfecting products for various periods 
of time has been demonstrated in several studies (Rosenthal, 
Henry, et al 2002; Dannelley et al 2004). These reports were 
largely ignored. Current FDA (ISO) stand-alone testing 
protocols are in-vitro tests and do not incorporate contact 
lenses.
Etiology of the fusarium outbreak
Postulating a mechanism that explains how a multipurpose 
contact lens disinfection solution could become a key element 
in a world wide outbreak of fungal keratitis is a daunting 
task. All modern contact lens solutions, including ReNu 
with MoistureLoc must pass relatively stringent testing 
that challenges effectiveness against a variety of potential 
pathogens – including Fusarium solani.
In January 2005, newly introduced Bausch and Lomb 
ReNu with MoistureLoc was subjected to a small pilot 
study exploring its compatibility with silicone hydrogel and 
conventional hydrogel lens materials (Epstein 2007). New 
unworn lenses were placed directly in conventional soft 
lens ﬂ  at-pack cases containing B&L ReNu with Moisture-
Loc. When the lenses were checked approximately a week 
later, several were covered with what appeared to be fungus. 
This was an unanticipated ﬁ  nding. In the northeast United 
States, fungal contamination of contact lenses is rare and 
usually is observed as small isolated focal fungal colonies 
invading the matrix of the lens. However, these lenses were 
extensively coated by fungal growth. Consultation with sev-
eral knowledgeable colleagues suggested that this was of no 
clinical signiﬁ  cance and the lenses were placed in storage and 
forgotten about. The experiment was recalled and the lenses 
recovered and cultured in May 2006. Several organisms 
were found including Fusarium solani. The experiment was 
repeated and several generations of lenses with signiﬁ  cant Clinical Ophthalmology 2007:1(4) 361
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fungal growth were produced using the original solution as 
an inoculum (Epstein 2007). This observation has been tested 
in several labs and reproduced. Publication is pending.
Previous research has shown how biocides can absorb 
into contact lens materials resulting in the solution losing 
disinfectant efﬁ  cacy (ISO 2001; Rosenthal, Sutton, et al 
2002). Recently, the contact lens uptake characteristics and 
fungicidal activity of alexidine, a small molecular weight 
monomeric biguanide in ReNu with MoistureLoc, has 
been compared to polyhexamethylene biguanide (PHMB) 
in Bausch & Lomb ReNu MultiPlus and AMO Complete 
MoisturePLUS and POLYQUAD (polyquaternium-1) 
and ALDOX (myristamidopropyl dimethylamine) used in 
OPTI-FREE RepleniSH (Rosenthal et al 2006).
Approximately 30% to 60% of the PHMB and alexidine 
were depleted from the solution within six hours. Diminished 
antimicrobial activity corresponded to decreases in disinfec-
tant concentration throughout the course of the evaluation. 
The polyquaternium-1 based solution maintained biocide 
concentration and consequently retained nearly 100% of its 
fungicidal activity.
Of note, the diminishing alexidine concentration of ReNu 
with MoistureLoc was reﬂ  ected in reduced antimicrobial 
efﬁ  cacy. ReNu with MoistureLoc showed an average 37% 
less fungicidal activity and an average of 54% less alexidine 
after a 6-hour soak period and showed an average 84% less 
activity and an average 88% less Alexidine biocide present 
in the 7-day old used solution. ReNu MultiPlus showed an 
average 71% less fungicidal activity with an average 19% 
less PHMB after six hours and 94% less fungicidal activity 
with an average drop of 50% biocide after seven-days.
Loss of disinfection efﬁ  cacy during the disinfection pro-
cess appears the most likely initiator of sustained Fusarium 
contamination of the solution, lens and case. As biocide is 
lost through contact lens material absorption, disinfectant 
efﬁ  cacy is reduced and the kill curve rapidly diminishes. 
Fusarium solani is a relatively hearty organism and may 
survive longer than most other pathogens that may be inad-
vertently inoculated by the patient during lens handling. 
Despite the activity of alexidine against Fusarium, clearly 
some organisms survive the initial high concentration of the 
biocide and persist while disinfectant levels fall to levels 
that are more hospitable to the organism. Fusarium strains 
have shown several properties that aid in their survival and 
may account for their selection (Zhang et al 2006). This is 
likely exacerbated by non-compliant reuse of the solution 
with “topping off” since the lens has been shown to absorb 
disinfectant (Rosenthal et al 2006). However, the mere 
survival of Fusarium organisms does not account for the 
level of infection observed.
The FDA/ISO disinfection standard represents a time 
kill curve. Product passage requires sufﬁ  cient kill within a 
stipulated time. The contribution of possible organism growth 
was not considered when the standards were promulgated. 
However, advances in lens care design as well as competi-
tive forces prompted Bausch & Lomb and other companies 
to formulate products with additives that boost moisture 
retention to improve patient comfort. The MoistureLoc 
formula contains polyquaternium-10, an organic compound 
commonly used in hair-care products. Polyquaternium-10 
is a weakly cationic cellulose derivative. Its charge facili-
tates adherence to the lens surface for sustained wettablity. 
Its cellulose content serves as a nutritive media that may 
facilitate fungal growth especially as disinfectant levels fall 
to sub-lethal levels. This accounts at least in part for the 
observed pattern of fungal growth on lenses. The persistence 
of Fusarium during the decaying disinfection cycle supports 
the concept that ReNu with MoistureLoc may function as a 
selective culture media.
Research performed by B&L has shown how the accu-
mulated polymer in MoistureLoc can serve to isolate and 
protect fungus. Polymer coating the lens surface, as it was 
designed to do, would serve to shield fungal organisms from 
high levels of disinfectant likely present at the surface of the 
lens. It would thus facilitate growth (Levy et al 1990). As 
disinfectant levels decline, the growth curve would overtake 
and exceed the kill curve of the disinfectant. This interaction 
has never been observed with contact lens care products 
as most predicate products lacked nutritive properties and 
disinfectant levels were assumed to remain static; however, 
these principals derive from current pharmacokinetic-
pharmacodynamic models of in vivo antibiotic function 
(Mueller et al 2004). Furthermore, they offer one of the 
few logical explanations for the intensity and geographic 
diversity of this epidemic.
The relation between corneal 
staining (barrier disruption)
and infection
Humans have been exposed to microbial pathogens since 
the origin of the species. As a result, a variety of effective 
defenses to bacterial, viral, fungal protozoan, and parasitic 
infection have evolved. This is especially true of the ocular 
surface, which is habitually in direct contact with the envi-
ronment. Defenses against microbial infection include: 
rapid epithelial healing, tight junctions, and brisk cell turn Clinical Ophthalmology 2007:1(4) 362
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over. These defenses are so effective that only ﬁ  ve bacteria 
are capable of invading an intact cornea: Neisseria gonor-
rhoeae, Corynebacterium diphtheriae, Listeria, Haemophilus 
aegyptius, and invasive strains of Pseudomonas aeruginosa 
(Fleiszig et all 1998).
Physical epithelial barriers comprise the ﬁ  rst line of defense 
against infection. Penetration of these innate natural host bar-
riers is therefore a key prerequisite for microbial infection. 
This is especially true of fungi. Although host defenses are 
complex and interwoven, intact epithelium serves as a primary 
defense against infection. This concept is so fundamental to 
infectious disease that it is unquestioned. The importance 
of the epithelium in protection against infection is obvious 
when the barrier is breached, as in wounds and burns, where 
infection is an obvious major cause of mortality and morbid-
ity (Janeway et al 2001). Disruption of physiologic epithelial 
barriers increases the risk of infection.
As discussed previously, fungal keratitis is relatively 
rare, especially outside of tropical and subtropical areas. 
Because fungi do not typically invade intact cornea, trauma, 
usually caused by plants or vegetable matter is considered 
the most common cause of fungal keratitis (Liesegang and 
Forster 1980). Ocular and systemic disease and prior cor-
ticosteroid treatment are additional risk factors (Thomas 
2003). In developing an animal model of Fusarium keratitis, 
Forster and Rebell found it necessary to scarify the cornea 
and pretreat with subconjunctival corticosteroids to obtain 
sustained culture-positive ulcers in high percentage of eyes 
(Forster and Rebell 1975).
A review of the clinical and microbiology records of the 
New York Eye and Inﬁ  rmary identiﬁ  ed sixty-one cases of 
fungal keratitis in ﬁ  fty-seven patients between January 1, 
1987 and June 1, 2003, a sixteen-year period. Of 5083 posi-
tive corneal cultures, sixty-one eyes in ﬁ  fty-seven patients 
were positive for fungus representing 1.2% of cases. Human 
immunodeﬁ  ciency virus (HIV) seropositivity, chronic ocular 
surface disease, and trauma were the most commonly associ-
ated risk factors (Ritterband et al 2006).
Contact lens associated fungal keratitis is rarely encoun-
tered, even in subtropical climates. In a 10 year review of 
records from January 1982 to January 1992 at South Florida’s 
Bascom Palmer Eye Institute only 4% of fungal keratitis 
cases were associated with contact lens wear (Rosa et al 
1994). Fungal infection in cosmetic contact lens wearers is 
rare, again representing only 4% of overall fungal keratitis 
cases in another large series (Wilhelmus et al 1988). Other 
estimates are as low as 1% of all cases of CL-MK (Rosenthal 
et al 2006).
Fluorescein staining (staining) of the ocular surface 
reveals epithelial trauma and barrier disruption. Staining is 
typically observed after instilling sodium ﬂ  uorescein solu-
tion or an alternative vital dye and examining the eye with 
a biomicroscope using special lighting and, in some cases, 
ﬁ  ltering techniques. Low grade corneal staining has been 
reported to occur spontaneously in successful contact lens 
wearers and non-contact lens wearers (Schwallie et al 1997; 
Jalbert et al 1999). Corneal staining may be asymptomatic 
even in severe cases. As a result, poor correlation exists 
between observed staining and patient symptoms (Jones 
et al 2002; Garofalo et al 2005; Epstein 2006). Regardless of 
cause or extent, staining represents a breakdown of normally 
protective barriers and logically increases the risk of infection 
and inﬂ  ammation (Carnt et al 2007).
Over the past few years, numerous reports describing 
corneal staining in contact lens wearers using different com-
binations of multipurpose solutions (MPS) and contact lens 
materials have been published, especially with the biguanide 
disinfectants such as Bausch and Lomb ReNu MultiPlus 
(Epstein 2002; Jones et al 2002; Pritchard et al 2003; Lebow 
and Schachet 2003; Andrasko et al 2006). Bausch and Lomb 
ReNu with MoistureLoc has also been associated with sig-
niﬁ  cant corneal staining in several investigations (Townsend 
et al 2005; Lebow and Schachet 2006).
The research of Andrasko and associates has been of 
particular value in understanding contact lens material and 
MPS product interactions. This series of well-constructed 
double masked (ongoing) studies has already evaluated more 
than ﬁ  fty different combinations of contact lenses and lens 
care products. Average corneal staining area is measured and 
reported. This data is charted on a color-coded grid for ease 
of interpretation (http://www.staininggrid.com – Figure 1). 
Results conﬁ  rm that staining varies substantially depending 
upon the MPS and lens combination tested.
Biguanide-based MPS showed higher levels of corneal 
disruption when paired with silicone hydrogel lenses. In 
particular, the combination of B&L’s Purevision (Balaﬁ  lcon 
A) lens and ReNu MultiPlus (PHMB) MPS produced the 
highest levels of average corneal staining area – 73%. This 
ﬁ  nding is consistent with prior reports (Epstein 2002; Jones 
et al 2002; Lebow and Schachet 2003).
B&L ReNu with MoistureLoc in combination with the 
conventional hydrogel Vistakon Acuvue 2 had relatively 
high levels of corneal staining – 25%. Although the CDC 
did not speciﬁ  cally report on the relation of lens type and 
infection rate, personal communication with clinicians at 
Bascom Palmer Eye Institute in Miami, FL and the Singapore Clinical Ophthalmology 2007:1(4) 363
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National Eye Institute in Singapore suggested the majority 
of contact lens-related Fusarium infections were in patients 
wearing Acuvue 2 or similar hydrophilic materials.
The risk of developing microbial keratitis depends 
upon several factors including: the extent of epithelial bar-
rier disruption, the magnitude of the infectious inoculum 
(introduced or present) within the ocular environment, the 
virulence of the organism and ﬁ  nally, the effectiveness of the 
host inﬂ  ammatory response (Lawin-Brussel et al 1993). The 
larger the surface area of epithelial compromise, the greater 
the probability that an organism (or multiple organisms) 
will gain entry into damaged areas of epithelium or corneal 
stroma and cause infection. Likewise, the larger the number 
of potentially infectious organisms present, the greater the 
probability of infection. Increased virulence of a pathogen 
will increase the chances of infection while effective humeral 
defenses will decrease the odds of infection.
The presence of a contact lens may play a role in infection 
by interfering with the normal ocular immune response. Since 
the cornea is avascular, polymorphonuclear leukocytes 
(PMN) must migrate from the conjunctival circulation to 
the site of infection. This acute inﬂ  ammatory response was 
blocked by a contact lens in a rabbit model of Pseudomonas 
keratitis (Lawin-Brussel et al 1995). In that regard, a contact 
lens may function as a mechanical anti-inﬂ  ammatory agent. 
The presence of a contact lens may have been a contributory 
factor in the ReNu with MoistureLoc outbreak.
Conclusion
The Fusarium outbreak was a virtually unprecedented occur-
rence in health care. Nearly 200 cases of Fusarium keratitis 
were reported to the US CDC, sixty-six cases were reported in 
Singapore and others occurred in Malaysia, China, India and 
several European countries. The full extent of the outbreak 
may never be known.
Some question if Bausch and Lomb waited too long 
before issuing a global recall of ReNu with MoistureLoc, 
worsening an already bad situation. Despite the convincing 
evidence of a link between the Fusarium outbreak and ReNu 
with MoistureLoc established in Singapore and mounting 
evidence in the US, B&L initially only stopped production 
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later, a limited recall was initiated in the US and patients and 
professionals were advised to discontinue using MoistureLoc. 
It wasn’t until weeks later that a global recall was issued. 
It appears that there was dissention within B&L during this 
period. Angela J. Panzarella, B&L vice president for global 
vision care, was quoted: “I wish we had made the decision 
the ﬁ  rst day not to sell or use it.” (Feder 2006).
Although many of the facts of this outbreak will ulti-
mately become clearer with time and additional investiga-
tion, there remains a great opportunity to learn from this 
experience.
In analyzing the specific factors that contributed to 
widespread Fusarium infection, comparison to normal trends 
of microbial keratitis is essential. Normal “background” 
CL-MK has been estimated to range from approximately 4 
in 10,000 for daily wear to 20 in 10,000 for extended-wear 
(Schein et al 1989; Cheng et al 1999). At the height of 
the Fusarium epidemic in Singapore the estimated annual 
national incidence was 2.35 cases per 10,000 wearers (Khor 
et al 2006).
Considering that fungal keratitis normally manifests as 
1 in every 5 cases of microbial keratitis in Singapore and 
contact lens related keratitis is generally a small fraction 
of that (approximately 6%), it is obvious that the numbers 
reported in Singapore are many times greater than expected 
(Wong et al 1997; Houang et al 2001). It is likely that analy-
sis of annualized infection incidence during the Fusarium 
outbreak would yield similar numbers for the US and other 
areas (Alfonso, Cantu-Dibildox et al 2006).
While some of the core elements of the infectious out-
break such as biocide uptake, loss of disinfection efﬁ  cacy, 
and some of the effects of the polymeric additives have 
already been investigated and reported, some critically 
important pieces of this puzzle remain unconﬁ  rmed. Five 
key elements of Fusarium infection associated with ReNu 
with MoistureLoc are depicted in Figure 2. Corneal staining 
likely plays an important role in the genesis of infection and 
deserves further investigation.
Of sixty-six patients infected in Singapore, sixty-two 
reported using B&L ReNu solutions. Of these, 63.6% 
reported using ReNu with MoistureLoc and the remaining 
30.3% appear to have been using B&L ReNu MultiPlus. 
In the CDC data, 69% of patients used ReNu with Mois-
tureLoc while 18% used ReNu MultiPlus. Even though this 
was below the expected usage rate based on market share, 
it still represents a disproportionate number compared to 
other brands.
These data when viewed in the context of the high levels 
of corneal staining reported with biguanide based MPS like 
ReNu MultiPlus, the recent data of Rosenthal and coworkers 
regarding loss of disinfectant efﬁ  cacy with ReNu MultiPlus 
and MoistureLoc and the report of Iyer et al regarding the 
ongoing increase in fungal CL-MK paints a disturbing pic-
ture; one that may be only the tip of the iceberg (Dannelley 
et al 2004; Iyer et al 2006; Mack 2006).
60 million individuals throughout the world wear 
contact lenses. While the risk of infection associated with 
contact lenses is generally perceived as small, perhaps a more 
appropriate perspective is that infection rates may in reality 
be needlessly high, especially if we can use this experience to 
identify speciﬁ  c risk factors and learn to modify them. During 
the Fusarium outbreak, many patients experienced intense 
pain, lost their sight or even their eyes. For these patients and 
for the millions of other contact lens wearers, it is critical that 
a thorough and comprehensive investigation be conducted. 
It is hoped that this paper will serve as a starting point and 
Figure 2 Key elements of Fusarium infection.
FIVE ELEMENTS OF THE FUSARIUM OUTBREAK
￿  Incremental loss of disinfectant efficacy (diminishing kill curve) due to biocide
uptake by lens 
￿  Selection of Fusarium due to persistence
￿  Fusarium growth supported by MoistureLoc polymeric protection on lens surface
and nutritive properties of cellulose (Growth curve exceeding kill curve) 
￿  Chemical trauma (corneal staining) upon lens insertion due to biocide release
￿  Blocking of host inflammatory response by lens Clinical Ophthalmology 2007:1(4) 365
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as a result contact lenses will continue to evolve into an ever 
safer and more effective form of vision correction.
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